Palvella Therapeutics, Inc. (PVLA) stock
PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
$146.58+2.23 (+1.54%)
Close on Nov 18, 2026Market cap $2.11BP/E –Yield –
Palvella Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Palvella Therapeutics's enterprise value was $2.11B on Nov 11, 2026, against $1.08B a year earlier. Over the last 5 years it ranged from -$36.07M to $2.11B, with a median of $38.26M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.11B | +92.3% |
| 2025 | Dec 31, 2025 | $1.10B | – |
| 2024 | Dec 31, 2024 | -$3.56M | – |
| 2023 | Dec 29, 2023 | -$29.53M | -489.4% |
| 2022 | Dec 30, 2022 | $7.58M | -94.8% |
| 2021 | Dec 31, 2021 | $145.19M | +153.3% |
| 2020 | Dec 31, 2020 | $57.33M | -38.1% |
| 2019 | Dec 31, 2019 | $92.60M | +1275.1% |
| 2018 | Dec 31, 2018 | $6.73M | -97.3% |
| 2017 | Dec 29, 2017 | $247.60M | +933.9% |
| 2016 | Dec 30, 2016 | $23.95M | -59.3% |
| 2015 | Dec 31, 2015 | $58.79M | – |
| 2014 | Dec 31, 2014 | -$524.43K | – |
See a number that looks wrong?